STRIDES PHARMA SCIENCE LTD.

NSE : STARBSE : 532531ISIN CODE : INE939A01011Industry : Pharmaceuticals & DrugsHouse : Private
BSE883.45-14.55 (-1.62 %)
PREV CLOSE ( ) 898.00
OPEN PRICE ( ) 900.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 21465
TODAY'S LOW / HIGH ( )870.35 900.95
52 WK LOW / HIGH ( )340 911.95
NSE886.55-10.25 (-1.14 %)
PREV CLOSE( ) 896.80
OPEN PRICE ( ) 896.80
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 886.55 (1957)
VOLUME 192861
TODAY'S LOW / HIGH( ) 870.00 896.80
52 WK LOW / HIGH ( )338.9 911.75
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 28-06 1990
Management Info
Arun Kumar - Chairman Arun Kumar - Managing Director
Registered Office

Address 201, Devavrata,Sector-17,Vashi,
Navi Mumbai,
Maharashtra-400703

Phone 022-27892924 / 3199

Email corpcomm@strides.com

Website www.strides.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX
NEWS
10Apr Strides Pharma Science gains as its ar
Strides Pharma Science is currently trading at Rs. 842.10, up by 4.20 po..
09Apr Strides Pharma Science’s arm gets USFD
Strides Pharma Science’s step-down wholly owned subsidiary -- Strides Ph..
09Apr Strides Pharma Science informs about p
Strides Pharma Science has informed that it attached a press release tit..
06Apr USFDA completes cGMP inspection at Che
United States Food and Drug Administration (USFDA) has completed a routi..
06Apr Strides Pharma Science informs about c
Strides Pharma Science has informed that a routine current Good Manufact..
Financials
Rs. in Millions
QTR Dec 23 ANNUAL 23
Net Profit25.420000000000846.8199999999966
Gross Profit 35.2000000000008 -647.600000000003
Operating Profit 743.4100000000011825.43
Net Sales 5200.1518544.96
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Ajanta Pharma (BSE)
 2377.00 (6.44%)
M.Cap (Rs. in Cr)29930.39
Alkem Laboratories (BSE)
 4899.45 (2.36%)
M.Cap (Rs. in Cr)58580.27
Astrazeneca Pharma I (BSE)
 5424.45 (1.70%)
M.Cap (Rs. in Cr)13561.13
Dr. Reddy's Lab (BSE)
 6349.95 (0.98%)
M.Cap (Rs. in Cr)105928.76
Torrent Pharma (BSE)
 2732.60 (2.20%)
M.Cap (Rs. in Cr)92483.60
Shareholding Pattern
NON-INSTITUTION 31.5%
PROMOTERS 25.88%
MUTUAL FUNDS/UTI 10.57%
FI/BANKS/INSURANCE 5.78%
GOVERNMENT 0.01%
FII 0%
ATTENTION INVESTORSKYCIPO
Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :
REGISTRATION NOS.

NSE CM-INZ000234235|NSE F& O - INZ000234235, NSE CD-INZ000234235, BSE CM–INZ000234235 |BSE F & O - INZ000234235|BSE CD- INZ000234235 MCX-SX CM-INZ000234235|MCX-SX F & O - INZ000234235|MCX-SX CD-INZ000234235 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016|SEBI-PMS: INP000007100|LEI- 3358007DLCFNHY8J2F96

Filing compliant on SCORES – Easy & quick

  • Register on SCORES portal
  • Mandatory details for filing complaints on SCORES:
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • Benefits:
    • i.) Effective communication
    • ii.) Speedy redressal of the grievances
INVESTOR PROTECTION

Compliance officer : Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075, E-mail ID: compliance@nnmsecurities.com, cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

"NNM Securities has partnered with TradingView for its charting technology. An investment and trading platform empowering users with global market data and analytical tools like Stock Screener and Economic Calendar."

Copyright © 2021 NNM Securities.com

Advanced Charts Technology Partner: TradingView

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.